Tumor-infiltrating lymphocyte therapy appears safe, effective in melanoma, cervical cancer

June 04, 2019 8:57 AM | Grant Dvorak (Administrator)

 June 4, 2019, HemOnc Today  

Data from two trials evaluating the safety and efficacy of adoptive cell transfer with autologous tumor-infiltrating lymphocytes showed promising overall response rates for the treatment of advanced metastatic melanoma and cervical cancer, according to results presented at ASCO Annual Meeting. 

Read more.

Powered by Wild Apricot Membership Software